XML 43 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Cash Flows - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Statement of cash flows [abstract]      
Net loss € (31) € (4) € (552)
Adjustments      
Depreciation and amortization 171 155 140
Finance costs-net 243 167 155
Income tax expense / (benefit) 80 69 (32)
Share of loss of joint-ventures 29 14 3
Unrealized (gains) / losses on derivatives-net and from remeasurement of monetary assets and liabilities-net (54) (74) 23
Losses on disposal 3 10 5
Impairment     457
Other-net 7 (14) 5
Interest paid (185) (174) (143)
Income tax paid (18) (14) (9)
Change in trade working capital      
Inventories (99) (42) 149
Trade receivables (91) 28 343
Margin calls     1
Trade payables 124 (18) (161)
Change in provisions and pension obligations (7) (5) (20)
Other working capital (12) (10) 4
Net cash flows from operating activities 160 88 368
Purchases of property, plant and equipment (276) (355) (350)
Acquisition of subsidiaries net of cash acquired   21 (348)
Proceeds from disposals net of cash 2 (5) 4
Equity contribution and loan to joint-ventures (41) (37) (34)
Other investing activities 23 11 6
Net cash flows (used in) / from investing activities (292) (365) (722)
Net proceeds received from issuance of shares 259    
Proceeds from issuance of Senior Notes 1,440 375  
Repayment of Senior Notes (1,559) (148)  
Proceeds / (Repayments) from revolving credit facilities and other loans 29 (69) (211)
Payment of deferred financing costs and exit fees (118) (19) (2)
Transactions with non-controlling interests   (2) 3
Other financing activities 10 8 45
Net cash flows from / (used in) financing activities 61 145 (165)
Net (decrease) / increase in cash and cash equivalents (71) (132) (519)
Cash and cash equivalents-beginning of period 347 472 991
Cash and cash equivalents classified as held for sale-beginning of period   4  
Effect of exchange rate changes on cash and cash equivalents (7) 3 4
Cash and cash equivalents-end of period 269 347 476
Less: cash and cash equivalents classified as held for sale     (4)
Cash and cash equivalents as reported in the Consolidated Statement of Financial Position € 269 € 347 € 472